Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-114P (RNA, U6 small nuclear 114, pseudogene) is a pseudogene that corresponds to the U6 small nuclear RNA (snRNA) family. U6 snRNA is a highly conserved component of the spliceosome, where it plays a central role in the catalysis of pre-mRNA splicing by forming base-pair interactions with other spliceosomal RNAs and positioning substrates for the splicing reaction[1][2][3]. However, as RNU6-114P is a pseudogene, it is a non-functional sequence that resembles a functional U6 small nuclear RNA gene but does not produce a functional RNA product and is not part of the active spliceosome machinery[4][2]. Pseudogenes like RNU6-114P are common for U6 snRNA, acting as genomic "backups" but do not have functional or therapeutic relevance[2]. Thus, RNU6-114P is not considered a drug target, does not have known biological functions, disease roles, or safety concerns, and is typically omitted in target-based research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on U6 small nuclear RNA 114, pseudogene (RNU6-114P).